SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 76 filers reported holding SCPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,150 | -17.4% | 16,594 | +18.3% | 0.00% | – |
| Q2 2023 | $142,955 | +376.5% | 14,029 | +212.1% | 0.00% | – |
| Q1 2021 | $30,000 | +15.4% | 4,495 | -8.7% | 0.00% | – |
| Q4 2020 | $26,000 | 0.0% | 4,924 | +40.4% | 0.00% | – |
| Q3 2020 | $26,000 | +44.4% | 3,508 | +41.8% | 0.00% | – |
| Q2 2020 | $18,000 | 0.0% | 2,474 | -23.1% | 0.00% | – |
| Q4 2019 | $18,000 | +260.0% | 3,217 | +75.8% | 0.00% | – |
| Q2 2019 | $5,000 | -80.0% | 1,830 | -78.5% | 0.00% | – |
| Q1 2019 | $25,000 | -24.2% | 8,504 | -5.4% | 0.00% | – |
| Q4 2018 | $33,000 | -80.8% | 8,993 | -69.6% | 0.00% | – |
| Q3 2018 | $172,000 | +20.3% | 29,568 | +15.7% | 0.00% | – |
| Q2 2018 | $143,000 | +22.2% | 25,550 | +170.1% | 0.00% | – |
| Q1 2018 | $117,000 | – | 9,460 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
| AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
| Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
| Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
| RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
| Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
| DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
| Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
| ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |